Liver Failure clinical trials

Explore recruiting liver failure clinical trials.

Recruiting liver failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, open-label, randomized, controlled, multi-center, proof of concept study, to assess the efficacy, safety, and tolerability of VS-01 on top of standard of care, compared to standard of care alone, in adult patients with acute-on-chronic liver failure (ACLF)

Germany, Belgium, Spain, France, Hungary, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital Mortality

France, Germany, Belgium, Spain, Italy, Austria +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cluster randomised trial of low molecular weight heparins - Directly through Epic

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF).

Germany, Spain, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, placebo-controlled, double blind, multi-centre Phase IIb stuDy to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) – DHELIVER

Denmark, Poland, Bulgaria, Netherlands, Slovakia, Latvia +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

PREDICTION OF COMPLICATIONS IN PATIENTS UNDERGOING SURGICAL TREATMENT OF HEPATIC TUMORS

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Liver Failure trials by city

Liver Failure in Toronto Liver Failure in Vancouver Liver Failure in Montreal Liver Failure in Calgary Liver Failure in Edmonton Liver Failure in Ottawa Liver Failure in Winnipeg Liver Failure in Quebec City Liver Failure in Hamilton Liver Failure in Kitchener Liver Failure in London Liver Failure in Halifax Liver Failure in New York Liver Failure in Los Angeles Liver Failure in Chicago Liver Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease